Treating chronic migraine in CADASIL with calcitonin gene-related peptide receptor antagonism
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical)
Reference7 articles.
1. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
2. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial;Tepper;Lancet Neurol,2017
3. Verifying the Stroke-Free Phenotype by Structured Telephone Interview
4. CADASIL: migraine, encephalopathy, stroke and their inter-relationships;Tan;PLoS One,2016
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports;Journal of Clinical Medicine;2024-03-24
2. Migraine treatment – updated recommendations 2024 –development of the Expert Group of the Headache Section ofthe Polish Neurological Society and the Polish Society for theStudy of Pain;BÓL;2024-03-18
3. Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review;Current Pain and Headache Reports;2022-09-05
4. Migraine treatment recommendations developed by an Expert Group of the Polish Headache Society, the Headache Section of the Polish Neurological Society, and the Polish Pain Society;Neurologia i Neurochirurgia Polska;2021-02-28
5. Introductory Chapter: Migraine in Post-Triptan Era – New Therapeutic Horizons;Migraine;2020-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3